Verseon

Verseon is redefining the delay, prevention, and treatment of diseases. By leveraging its unique physics-enhanced artificial intelligence platform, Verseon is continuously introducing a series of life-changing drugs. Each of the company’s drug programs features multiple novel candidate drugs with unique therapeutic properties. These candidates cannot be discovered through current alternative methods. Verseon's pipeline currently includes seven drug programs spanning areas such as anticoagulation, diabetic retinopathy, hereditary angioedema, oncology, and metabolic disorders.